Evidence map›Paper›PMID 19229320›Full record

ArticlePLoS pathogens2009

An antiviral response directed by PKR phosphorylation of the RNA helicase A.

Anthony J Sadler, Olivier Latchoumanin, David Hawkes, Johnson Mak, Bryan R G Williams

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Complementary regulation of caspase-1 and IL-1β reveals additional mechanisms of dampened inflammation in bats.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anthony J SadlerCentre for Cancer Research, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia. anthony.sadler@med.monash.edu.au
Olivier Latchoumanin
David Hawkes
Johnson Mak
Bryan R G Williams
Burnet Institute · AUMonash Institute of Medical Research · AUMonash University · AU

Funding

REGULATION OF INTERFERON-INDUCED DSRNA-ACTIVATED KINASER01AI034039 · NIAID · MONASH UNIVERSITY · PI WILLIAMS, BRYAN R. G. · 1993 to 2008
$2.5M
NIAID NIH HHS R01 AI034039NIAID NIH HHS R01 AI034039-14
6 · The paper itself

Abstract

The double-stranded RNA-activated protein kinase R (PKR) is a key regulator of the innate immune response. Activation of PKR during viral infection culminates in phosphorylation of the alpha subunit of the eukaryotic translation initiation factor 2 (eIF2alpha) to inhibit protein translation. A broad range of regulatory functions has also been attributed to PKR. However, as few additional PKR substrates have been identified, the mechanisms remain unclear. Here, PKR is shown to interact with an essential RNA helicase, RHA. Moreover, RHA is identified as a substrate for PKR, with phosphorylation perturbing the association of the helicase with double-stranded RNA (dsRNA). Through this mechanism, PKR can modulate transcription, as revealed by its ability to prevent the capacity of RHA to catalyze transactivating response (TAR)-mediated type 1 human immunodeficiency virus (HIV-1) gene regulation. Consequently, HIV-1 virions packaged in cells also expressing the decoy RHA peptides subsequently had enhanced infectivity. The data demonstrate interplay between key components of dsRNA metabolism, both connecting RHA to an important component of innate immunity and delineating an unanticipated role for PKR in RNA metabolism.

Indexed as

Binding SitesDEAD-box RNA HelicaseseIF-2 KinaseHIV-1HIV Long Terminal RepeatHumansImmunity, InnateMass SpectrometryNeoplasm ProteinsPeptide FragmentsRNA, Double-StrandedSequence Analysis, ProteinSignal TransductionTranscription, GeneticVirionDEAD-box RNA HelicasesDHX9 protein, humaneIF-2 KinaseNeoplasm ProteinsPeptide FragmentsRNA, Double-Stranded

Identifiers

PMID19229320
PMCPMC2637979
OpenAlexW2042372666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.